Hepatitis C virus: Biological and clinical consequences of genetic heterogeneity

Scandinavian Journal of Gastroenterology, Supplement

Volumn 31, Issue 218, 1996, Pages 106-115

  Cooreman, M P ^a   Van De Ven, E M E Schoondermark ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antiviral treatment; Chronic HCV disease; Disease severity; Genomic heterogeneity; Genotypes

Indexed keywords

CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CONFERENCE PAPER; DISEASE SEVERITY; DISEASE TRANSMISSION; GENE STRUCTURE; GENETIC HETEROGENEITY; GENOTYPE; HEPATITIS; HEPATITIS C VIRUS; IMMUNOASSAY; LIVER CIRRHOSIS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIREMIA; VIRUS INFECTION; VIRUS MORPHOLOGY; CLINICAL TRIAL; GENETICS; HEPATITIS C; HUMAN; PREVALENCE; PROGNOSIS; REVIEW;

CLINICAL TRIALS; GENETIC HETEROGENEITY; HEPACIVIRUS; HEPATITIS C; HUMANS; PREVALENCE; PROGNOSIS;

EID: 0030338551     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA derived from a blood-borne non-A, non-B hepatitis genome. Science 1989;244:359-62.
2. Barrera JM, Bruguera M, Ercilla MG, Sanchez-Tapias JM, Gil MP, Costa J, et al. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies for hepatitis C virus and surrogate markers. Ann Intern Med 1991;115:596-600.
3. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
4. Stevens CE, Taylor PE, Pindyck J, Choo QL, Bradley DW, Kuo G, et al. Epidemiology of hepatitis C virus: a preliminary study in volunteer blood donors. JAMA 1990;263:49-53.
5. Sirchia G, Almini D, Bellobuono A, Giovanetti AM, Marconi M, Mercuriali F, et al. Prevalence of hepatitis C virus antibodies in Italian blood donors. Vox Sang 1990;59:26-9.
6. Van der Poel CL, Reesinck HW, Lelie PN, Leentvaar-Kuypers A, Choo QL, Kuo G, et al. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet 1989;2:297-8.
7. Saeed AA, Al Admawi A, Al Rasheed A, Fairclough D, Bacchus R, Ring C, et al. Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet 1991;338:459-60.
8. Simmonds P. Variability of Hepatitis virus. Hepatology 1995;21:570-83.
9. Choo QL, Kuo G, Ralston R, Weiner A, Chien D, Van Nest G, et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA 1994;91:1294-8.
10. Sherlock DS. Chronic hepatitis C. Dis Mon 1994;40:117-96.
11. Alter AJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander J, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-905.
12. Esteban JI, Lopez-Talavera JC, Genesca J, Madoz P, Viladomiu L, Muniz E, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991;115:443-9.
13. Kao JH, Tsai SL, Chen PJ, Yang PM, Sheu JC, Lai MY, et al. A clinicopathologic study of chronic non-A, non-B (type C) hepatitis in Taiwan: comparison between posttransfusion and sporadic patients. J Hepatol 1994;21:244-9.
14. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrilo RP, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. N Engl J Med 1989;321:1501-6.
15. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle J, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991;14:969-74.